“…[19][20][21] since the mid-1990s, with its first use in an infant and followed by a small series in adults, 19,21,22 is therapy for Coa has gained acceptance as a primary option for treating native and recurrent Coa in adolescents and adults. 10,11,15,23,24 significant technological advances have been made in recent years to achieve the desirable characteristics of an ideal stent, including higher flexibility, lower profile, the ability to further dilate to adult size with somatic growth, minimal foreshortening with maximal expansion, high radial strength, non-sharp edges, and open cell strut configuration when a brachiocephalic vessel requires overlapping. 2,10,23 figure 1 shows the most commonly used stents for treatment of Coa, and table 1 and figure 2 summarize the characteristics and radial strengths of stents …”